Going digital is not about Social media or Omni channels. Is it about asking simple questions. Best Buy is one of the largest electronic good retailers in USA. Few years ago Best Buy was threatened by what is now known as Showrooming effect. Basically customers would walk into its showrooms get benefitted by the advice of the salesperson, decide on the model and then go online to buy the product on Amazon because of low prices. Despite having one the best footfalls in the decade Best Buy recorded reduced profits. Although it did try to Price match Amazon they knew it was not a long-term solution because of its cost structure (Physical showrooms, salespeople etc). They couldn’t block the customers from checking price of product on Amazon. Future looked uncertain, everyone thought game over for Best Buy which was the case with many other retailing giants. No amount of investing new technology would have helped Best Buy . Best Buy relearned how to make profits. Best Buy proposed to the manufacturers that they compensate Best Buy for exclusive showcasing of manufacturers new products. Manufacturers also could launch specific brand kiosks within Best Buy showroom for a fee. This new model which had zero investment for Best Buy dramatically increased its profitability. Is this a ground breaking innovation? Of course NO. This has already been practiced in other industries but for the first time tried in Electronic good Retail. Best Buy realized apart from consumers it created lot of value for manufacturers therefore it captured the value lost from consumers from manufacturers. What is my business? What is my business ecosystem? How do I currently make money? How changing one thing impacts my ecosystem? What are the options available?

How a Delhi Dementia Daycare Is Reimagining Care for India’s Forgotten Millions

By MedicinMan Editorial Desk When Memory Fades, Humanity Must Not In...

The Semaglutide Story: How One Molecule Re‑wired Obesity, Patents and Pharma Profits

1. From Gut Hormone to “Wonder Drug” If you strip...

Contact Us
Terms of Service
Privacy Statement

Facebook

Twitter

Youtube

Healthcare Trends

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

"Those who cannot remember the past are condemned to...

Brecht Vanneste has been appointed as Managing Director of MSD India

He steps into the role with a clear mandate...

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Opening Frame: The "Silent" Pandemic Meets Strategic Grit In the...

Marketing

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

"Those who cannot remember the past are condemned to...

Brecht Vanneste has been appointed as Managing Director of MSD India

He steps into the role with a clear mandate...

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Opening Frame: The "Silent" Pandemic Meets Strategic Grit In the...

Policies/Sales

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

"Those who cannot remember the past are condemned to...

Brecht Vanneste has been appointed as Managing Director of MSD India

He steps into the role with a clear mandate...

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Opening Frame: The "Silent" Pandemic Meets Strategic Grit In the...

Strategy

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...

The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy

"Those who cannot remember the past are condemned to...

Brecht Vanneste has been appointed as Managing Director of MSD India

He steps into the role with a clear mandate...

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Opening Frame: The "Silent" Pandemic Meets Strategic Grit In the...

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Digital Noise to Digital Voice – A 4-Module Workshop for Pharma People

https://www.youtube.com/watch?v=BOO_CNxEzwQ When Covid19 struck for the first time in March 2020, the...

Boehringer Ingelheim India focuses on partnerships in NCD management

Addressing the media at a roundtable this morning, Vani Manja, Managing Director, Boehringer Ingelheim India said, “Boehringer Ingelheim India aspires to be amongst the top five multinational pharmaceutical companies in India over the next few years. We have been enabling access to our innovator products to patients across India and the neighbouring markets in the diabetes, cardiovascular, stroke and respiratory diseases segments. Our plan in these therapy areas is to build sustainable partnerships to ensure an ecosystem of access and care for patients. We have initiated action in that direction.”

Crafting a Digital Strategy: The Roadmap for 2021

In many situations, technology upgradation is often construed as digital transformation. In a recently conducted survey by Altimeter, 88% of companies said that they were undergoing ‘digital transformation’ but only 25% said that they did so with the purpose beyond investing in new technology. The real definition of digital transformation is the realignment of, or new investment in technology, business models, and processes to create value for customers in a dynamic digital economy.